EF
AZN icon

Empowered Funds’s AstraZeneca AZN Stock Holding History

Empowered Funds’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.83M Buy
+19,430
New +$3.75M 0.02% 756
2025
Q4 		– Sell
-14,100
Closed -$2.16M – 1074
2025
Q3 		$2.16M Buy
+14,100
New +$2.13M 0.02% 887

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

Empowered Funds's AZN Position: Q1 2026 in Review

Empowered Funds opened a new position in AstraZeneca (AZN) in Q1 2026: 19,430 shares worth $3.83M. The stake represents 0.02% of the portfolio and ranks #756 among its holdings. This is a return to the name: Empowered Funds previously reported a position in AZN as recently as Q3 2025.

Empowered Funds first reported a position in AZN in Q3 2025 and has held it in 2 quarters since. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Empowered Funds held 19,430 shares of AstraZeneca worth $3.83M as of Q1 2026.
  • AstraZeneca was a new Empowered Funds position in Q1 2026.
  • AstraZeneca made up 0.02% of Empowered Funds's portfolio in Q1 2026, its #756 holding.
  • Empowered Funds first reported a position in AstraZeneca in Q3 2025 and has held it in 2 quarters since.
  • 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Empowered Funds's 13F filing for Q1 2026, filed 15 May 2026.